| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 12 |
| 1 | PRAZIQUANTEL | 11 |
| 2 | MYCOPHENOLATE MOFETIL | 8 |
| 3 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 8 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 8 |
| 5 | TACROLIMUS OINTMENT 0.1% | 8 |
| 6 | BASILIXIMAB | 7 |
| 7 | LAMIVUDINE | 6 |
| 8 | PREDNISOLONE | 6 |
| 9 | PREDNISOLONE ORAL | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PRAZIQUANTEL | 11 | 0.0363 |
| 1 | PYRIMETHAMINE | 3 | 0.0024 |
| 2 | IVERMECTIN | 5 | 0.0011 |
| 3 | BASILIXIMAB | 7 | 0.0006 |
| 4 | DOLUTEGRAVIR SODIUM AND LAMIVUDINE | 2 | 0.0006 |
| 5 | ALBENDAZOLE | 1 | 0.0005 |
| 6 | LAMIVUDINE AND ZIDOVUDINE | 4 | 0.0005 |
| 7 | LOXAPINE | 2 | 0.0005 |
| 8 | ZIDOVUDINE | 4 | 0.0004 |
| 9 | NEOMYCIN SULFATE | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthelmintic [EPC] | 12 | 0.0041 |
| 1 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 3 | 0.0024 |
| 2 | Antiparasitic [EPC] | 5 | 0.0011 |
| 3 | Pediculicide [EPC] | 5 | 0.0011 |
| 4 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 15 | 0.0003 |
| 5 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 6 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 12 | 0.0001 |
| 7 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 8 | Antimalarial [EPC] | 1 | 0.0001 |
| 9 | Antiprotozoal [EPC] | 1 | 0.0001 |